Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurovascular Effects of Empagliflozin in Mid-Life and Older Adults With Prehypertension

NCT07799441 is registered in ClinicalTrials.gov with Kanokwan Bunsawat as lead sponsor.

NCT NCT07799441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07799441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurovascular Effects of Empagliflozin in Mid-Life and Older Adults With Prehypertension
Lead sponsor
Kanokwan Bunsawat
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
January 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, endothelial dysfunction